Your browser doesn't support javascript.
loading
Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
Grbesa, Ivana; Pajares, María J; Martínez-Terroba, Elena; Agorreta, Jackeline; Mikecin, Ana-Matea; Larráyoz, Marta; Idoate, Miguel A; Gall-Troselj, Koraljka; Pio, Ruben; Montuenga, Luis M.
Affiliation
  • Grbesa I; Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain; Group for Translational Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia.
  • Pajares MJ; Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain; Department of Histology and Pathology, School of Medicine, University of Navarra, 31008 Pamplona, Spain; Navarra's Health Research Institute (IDISN
  • Martínez-Terroba E; Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain; Department of Histology and Pathology, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
  • Agorreta J; Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain; Department of Histology and Pathology, School of Medicine, University of Navarra, 31008 Pamplona, Spain; Navarra's Health Research Institute (IDISN
  • Mikecin AM; Laboratory of Experimental Therapy, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia.
  • Larráyoz M; Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
  • Idoate MA; Navarra's Health Research Institute (IDISNA), Pamplona, Spain; Department of Pathology, University Hospital and Faculty of Medicine, University of Navarra, 31008 Pamplona, Spain.
  • Gall-Troselj K; Laboratory of Epigenomics, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia.
  • Pio R; Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain; Navarra's Health Research Institute (IDISNA), Pamplona, Spain; Department of Biochemistry and Genetics, School of Science, University of Navarra, 3
  • Montuenga LM; Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain; Department of Histology and Pathology, School of Medicine, University of Navarra, 31008 Pamplona, Spain; Navarra's Health Research Institute (IDISN
PLoS One ; 10(4): e0124670, 2015.
Article in En | MEDLINE | ID: mdl-25915617
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression / Carcinoma, Non-Small-Cell Lung / Sirtuin 1 / Sirtuin 2 / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Affiliation country: Croatia Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression / Carcinoma, Non-Small-Cell Lung / Sirtuin 1 / Sirtuin 2 / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Affiliation country: Croatia Country of publication: United States